Yan Ming's Insider Trades & SAST Disclosures
Yan Ming's most recent trade in Cytek BioSciences Inc was a trade of 9,817 Common Stock done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Yan Ming.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 9,817 | 6,029,532 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 9,817 | 58,911 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,366 | 66,302 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,366 | 6,033,987 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.36 per share. | 10 Mar 2025 | 2,911 | 6,026,621 | - | 4.4 | 12,692 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.36 per share. | 10 Mar 2025 | 2,185 | 6,031,802 | - | 4.4 | 9,527 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 156,250 | 156,250 | - | - | Employee Stock Option (right to buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 98,607 | 98,607 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,981 | 7,275 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,981 | 6,020,303 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.31 per share. | 18 Feb 2025 | 588 | 6,019,715 | - | 5.3 | 3,122 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 7,363 | 68,728 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 7,363 | 6,015,936 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 5,525 | 73,668 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 5,525 | 6,019,668 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 1,981 | 9,256 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 1,981 | 6,009,056 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 1,793 | 6,014,143 | - | 6.0 | 10,812 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 1,346 | 6,018,322 | - | 6.0 | 8,116 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 18 Nov 2024 | 483 | 6,008,573 | - | 6.0 | 2,912 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 7,363 | 76,091 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 7,363 | 6,004,693 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 5,525 | 79,193 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 5,525 | 6,008,421 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,981 | 5,997,918 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,981 | 11,237 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 1,797 | 6,002,896 | - | 5.5 | 9,937 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 1,346 | 6,007,075 | - | 5.5 | 7,443 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 588 | 5,997,330 | - | 5.5 | 3,252 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,980 | 83,454 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,908 | 5,994,803 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 3,683 | 84,718 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 3,683 | 5,997,030 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,981 | 13,218 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,981 | 5,990,483 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 1,456 | 5,993,347 | - | 6.0 | 8,678 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 1,093 | 5,995,937 | - | 6.0 | 6,514 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 588 | 5,989,895 | - | 6.0 | 3,504 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 5.87 per share. | 19 Apr 2024 | 20,000 | 5,988,502 | - | 5.9 | 117,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 09 Apr 2024 | 1,500 | 6,008,902 | - | 7 | 10,500 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 09 Apr 2024 | 400 | 6,008,502 | - | 7.0 | 2,804 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 6.77 per share. | 18 Mar 2024 | 20,000 | 6,030,402 | - | 6.8 | 135,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 6.71 per share. | 18 Mar 2024 | 20,000 | 6,010,402 | - | 6.7 | 134,200 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 9,817 | 6,053,313 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 9,817 | 88,362 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.22 per share. | 11 Mar 2024 | 2,911 | 6,050,402 | - | 7.2 | 21,017 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 131,578 | 131,578 | - | - | Employee Stock Option (right to buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 88,401 | 88,401 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,981 | 6,044,084 | - | - | Common Stock | |
| Cytek BioSciences Inc | Yan Ming | Director, CHIEF TECHNOLOGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,981 | 15,199 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Yan Ming | Director, CHIEF TECHNOLOGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.38 per share. | 20 Feb 2024 | 588 | 6,043,496 | - | 8.4 | 4,927 | Common Stock |
| Cytek BioSciences Inc | Yan Ming | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.43 per share. | 19 Dec 2023 | 20,000 | 6,042,103 | - | 9.4 | 188,600 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.07 per share. | 18 Aug 2023 | 20,000 | 7,815,962 | - | 8.1 | 161,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 7,363 | 7,838,830 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 7,363 | 105,542 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 18 Aug 2023 | 2,868 | 7,835,962 | - | 8.5 | 24,263 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 1,981 | 19,161 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 1,981 | 7,832,239 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 18 Aug 2023 | 772 | 7,831,467 | - | 8.5 | 6,531 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 19 Jul 2023 | 20,000 | 7,830,258 | - | 8.8 | 175,200 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 20 Jun 2023 | 20,000 | 7,850,258 | - | 8.2 | 163,600 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.71 per share. | 19 Apr 2023 | 20,000 | 7,886,053 | - | 9.7 | 194,200 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.29 per share. | 20 Mar 2023 | 20,000 | 7,906,053 | - | 9.3 | 185,800 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 178,062 | 178,062 | - | - | Employee Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 117,813 | 117,813 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.94 per share. | 21 Feb 2023 | 20,000 | 7,926,053 | - | 10.9 | 218,800 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 1,981 | 7,946,825 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 1,981 | 23,123 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.97 per share. | 21 Feb 2023 | 772 | 7,946,053 | - | 11.0 | 8,469 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.53 per share. | 08 Feb 2023 | 897 | 7,944,844 | - | 13.5 | 12,136 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 03 Feb 2023 | 1,081 | 7,945,752 | - | 13.5 | 14,594 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.55 per share. | 03 Feb 2023 | 11 | 7,945,741 | - | 13.5 | 149 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 19 Jan 2023 | 20,000 | 7,946,833 | - | 11.0 | 220,600 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.38 per share. | 19 Dec 2022 | 20,000 | 7,966,833 | - | 10.4 | 207,600 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.66 per share. | 18 Nov 2022 | 20,000 | 7,986,833 | - | 14.7 | 293,200 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 1,981 | 25,104 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 1,981 | 8,007,605 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.75 per share. | 18 Nov 2022 | 772 | 8,006,833 | - | 14.8 | 11,387 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.42 per share. | 19 Oct 2022 | 20,000 | 8,005,624 | - | 14.4 | 288,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.42 per share. | 19 Sep 2022 | 20,000 | 8,025,624 | - | 12.4 | 248,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 19 Jul 2022 | 20,000 | 8,064,415 | - | 11.8 | 236,600 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.06 per share. | 21 Jun 2022 | 20,000 | 8,084,415 | - | 10.1 | 201,200 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 9.92 per share. | 18 May 2022 | 20,000 | 8,104,415 | - | 9.9 | 198,400 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,642 | 8,125,445 | - | - | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,642 | 29,066 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.65 per share. | 18 May 2022 | 1,030 | 8,124,415 | - | 9.7 | 9,940 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 19 Apr 2022 | 20,000 | 8,122,803 | - | 10.3 | 206,800 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 21 Mar 2022 | 20,000 | 8,142,803 | - | 11.6 | 232,800 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.25 per share. | 07 Mar 2022 | 62,456 | 8,152,248 | - | 0.3 | 15,614 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 62,456 | 0 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 10,555 | 16,111 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.92 per share. | 07 Mar 2022 | 10,555 | 8,162,803 | - | 0.9 | 9,711 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 47,841 | 47,841 | - | - | Stock Option (Right to Buy) | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 31,708 | 31,708 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 22 Feb 2022 | 20,000 | 8,089,792 | - | 13.4 | 268,800 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 10 Feb 2022 | 14,706 | 8,115,086 | - | 15.0 | 220,737 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.37 per share. | 10 Feb 2022 | 5,294 | 8,109,792 | - | 15.4 | 81,369 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges